Adverse Drug Effects in Patients with CKD : Primum Non Nocere
| Errataetall: |
CommentOn: Clin J Am Soc Nephrol. 2020 Jul 1;:. - PMID 32611662 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Clinical journal of the American Society of Nephrology : CJASN - 15(2020), 8 vom: 07. Aug., Seite 1075-1077 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Perazella, Mark A [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 12.05.2021 Date Revised 21.04.2023 published: Print-Electronic CommentOn: Clin J Am Soc Nephrol. 2020 Jul 1;:. - PMID 32611662 Citation Status MEDLINE |
|---|
| doi: |
10.2215/CJN.08890620 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311895182 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311895182 | ||
| 003 | DE-627 | ||
| 005 | 20231225143233.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2215/CJN.08890620 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1039.xml |
| 035 | |a (DE-627)NLM311895182 | ||
| 035 | |a (NLM)32611663 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Perazella, Mark A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Adverse Drug Effects in Patients with CKD |b Primum Non Nocere |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.05.2021 | ||
| 500 | |a Date Revised 21.04.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Clin J Am Soc Nephrol. 2020 Jul 1;:. - PMID 32611662 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a acute kidney injury | |
| 650 | 4 | |a chronic | |
| 650 | 4 | |a chronic kidney disease | |
| 650 | 4 | |a drug toxicity | |
| 650 | 4 | |a drug-related side effects and adverse reactions | |
| 650 | 4 | |a glomerular filtration rate | |
| 650 | 4 | |a hemorrhage | |
| 650 | 4 | |a pharmacology | |
| 650 | 4 | |a renal insufficiency | |
| 650 | 4 | |a renin-angiotensin system blockers | |
| 650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
| 700 | 1 | |a Nolin, Thomas D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical journal of the American Society of Nephrology : CJASN |d 2006 |g 15(2020), 8 vom: 07. Aug., Seite 1075-1077 |w (DE-627)NLM172123720 |x 1555-905X |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2020 |g number:8 |g day:07 |g month:08 |g pages:1075-1077 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2215/CJN.08890620 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2020 |e 8 |b 07 |c 08 |h 1075-1077 | ||